Steve Schonfeld’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
Steve Schonfeld's JANX Position: Q3 2026 in Review
Steve Schonfeld reduced its Janux Therapeutics (JANX) stake by 57% in Q3 2026, selling an estimated $387K and leaving 17,106 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.
Steve Schonfeld first reported a position in JANX in Q1 2024 and has held it in 8 quarters since. The position peaked at $10.2M in Q2 2024. 204 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- Steve Schonfeld held 17,106 shares of Janux Therapeutics worth $296K as of Q3 2026.
- Steve Schonfeld sold 23,055 Janux Therapeutics shares in Q3 2026, an estimated $387K.
- Janux Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2206 holding.
- Steve Schonfeld first reported a position in Janux Therapeutics in Q1 2024 and has held it in 8 quarters since.
- Steve Schonfeld's Janux Therapeutics position peaked at $10.2M in Q2 2024.
- 204 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.